Purpose: We evaluated the results of microvascular penile revascularization in impotent men and carefully selected those whose vasculogenic impotence was de®ned as arteriogenic impotence, veno-cavernous leakage or mixed vasculogenic impotence. Materials and methods: Over a period of 11 y, 114 patients were treated for vasculogenic impotence with two surgical procedures: Michal II arterial bypass (44 patients) and modi®ed Furlow±Fisher technique of deep dorsal vein arterialization (DDVA) (70 patients). Initial evaluation included history, physical and neurological examination, hormonal level determination, pharmacological erection test, Rigiscan, duplex ultrasonography, selective pudendal arteriography, dynamic cavernosometry and cavernosography. The patients were followed up for a mean period of 17 months and the results were clinically evaluated. Results: The results at the end of one month were considered as good in 69.5% and improved in 12.2% and failed in 18.3%. Follow-up results are good in 47.8%, improved in 14.6% and failed in 37.4%. The best success rate was obtained with patients with pure venogenic impotence treated with DDVA, whereas the worst was observed in patients with pure arteriogenic impotence treated with the Michal II procedure. DDVA seems to provide better results than arterial bypass regardless of the etiology of impotence. Conclusions: Penile microvascular revascularization is not the best cure for all impotent men but appears to have a place in the treatment for selected patients with vasculogenic impotence. Further studies will be necessary to de®ne parameters able to permit a better understanding and selection of candidates.
Introduction
The understanding of the penile erection physiology has been dramatically improved during the last twenty years after the discovery to induce pharmacologically an erection. 1 Numerous studies assessing arterial in¯ow and veno-occlusive mechanisms led to better approaches of erectile dysfunction. It appears that vasculogenic impotence, including arterial insuf®ciency and veno-cavernous incompetence, represents the major causes of erectile dysfunction. 2 While intracavernous injections of vasoactive agents are the most popular treatments for erectile dysfunction, it is often ineffective in the cases of vasculogenic impotence. Even when this treatment is effective, it is stopped in 40% of patients after one year. 3 Other therapeutic options are the`vacuum' device, the penile prosthetic implants and the microvascular surgery.
4±6
Different success rates have been reported and published since the ®rst description of themicrovascular revascularisation of the penis by Michal in 1973. 7,40 According to the controversial results of the different revascularisation procedures in the literature (success rates ranging from 15±80%), 6 ,8±10,20,22 we report our experiences with 114 patients operated with two procedures: microvascular arterial bypass between the inferior epi-gastric and the penile dorsal arteries (Michal II) and deep dorsal vein arterialisation (DDVA). 21 
Materials and methods
From January 1985 to December 1995, 114 patients underwent 115 microvascular penile revascularisation (1 patient had two procedures), consisting of a Michal II arterio-arterial bypass in 44 cases (38.3%) and deep dorsal vein arterialisation in 71 cases (61.7%).
Patients selection
All patients underwent an evaluation that included history, physical and neurological examination, baseline laboratory studies and hormonal level determination. Patients older than 60 y, patients with diabetes, hypertension or smokers were informed of a great risk of failure but were not excluded at the beginning of our study. In all cases, Rigiscan over two consecutive nights con®rmed the organic etiology of impotence. For 91% of these patients, intracavernous injection of 20 mg of papaverine and of 20 mg of PGE1 failed to induce a rigid erection. In the other 9% this pharmacological test was positive but one patient refused self injection therapy.
The hemodynamic of the penis has been studied by duplex ultrasonography, selective pudendal arteriography, dynamic cavernosometry and cavernography. 2, 3 In our earlier study, ultrasonography was performed only to evaluate the peno-brachial index. Duplex ultrasonography is currently done before and after intracavernous injection of 20 PGE1. An adequate examination was de®ned as showing peak ow velocity greater than 25 cm/s in each cavernous artery. Selective pudendal arteriography was performed to document segmental arterial occlusive disease. 25 Arteriography was done after intracavernous injection of 10 mg papaverine in order to induce a vasodilatation of the penile arteries. Only patients showing bilateral pathologic angiograms were considered as suffering from arteriogenic impotence, either pure or associated with veno-cavernous dysfunction ( Figure 1 ).
Patients with unobstructed distal arteries on at least one side were considered for arterio-arterial bypass, while patients with bilateral lesions of the distal network were treated with DDVA. Pharmacocavernosometry was used to de®ne veno-cavernous leakage. An intracavernosal injection of 10±40 mg of papaverine was given in our earlier study, 20 mg of PGE1 are currently used. The infusion rate was increased until either an erection has been produced or a rate of 250 ml/min had been achieved. When an erection was obtained, the rate was slowed to determine the erection maintenance rate. The inability to achieve an erection or a maintenance rate b 40 ml/min were considered for the diagnosis of venogenic impotence. The site of the leakage was demonstrated by injecting contrast medium during the steady state of infusion.
The choice of the surgical procedure was based on the etiological diagnosis of impotence and on the study of the distal penile vascular network. Since 1986, DDVA has progressively taken a greater place in our practice. The different procedures relative to the etiology of erectile dysfunction are presented in Table 1 .
Surgical procedure
Both Michal II and DDVA procedures were performed using the inferior epigastric artery which was isolated by a paramedian incision alongside the rectus muscle. Papaverine was used to prevent arterial vasospasm. Five minutes before the artery was divided at the level of the umbilicus, 5000 units of heparin were administered intravenously. The Figure 1 Bilateral pudendal arteriography reveals a total occlusion of penile arteries. artery was brought through a subcutaneous tunnel to the root of the penis. A dorsal longitudinal incision was made at the base of the penis and the Buck's fascia was incised. The vascular elements were dissected with the aid of a microscope to avoid damage to the nervous system. For the Michal II procedure, an end to side anastomosis was performed between the epigastric artery and the proximal part of the dorsal artery using interrupted sutures of 9-0 nylon ( Figure 2 ). DDVA was performed with a modi®ed Furlow±Fisher procedure, 19±24 the epigastric artery was anastomosed end to side to the proximal part of the deep dorsal vein, the circum¯ex collaterals were preserved, the deep dorsal vein valves were not disrupted (Figures 3 to 5 ). When the anastomosis was completed, the dorsal vein was ligated proximal to the arterio-venous shunt and distal to the retrocoronal plexus. 
Post-operative care
The urethral catheter was removed after day 1, parietal drain after day 2. The patients received intravenous heparin for 72 h, after which they were placed on subcutaneous calciparine or low weight heparin for two months, and then on dipyridamole 75 mg o.d. and aspirin 500 mg. o.d. for 3 months. 40 Mean duration of hospitalisation was 10 d (range: 2± 32).
Follow-up
Patients on follow-up were consulted and the patency of the anastomosis was evaluated at regular intervals. The patients who were lost to follow-up at the time of the study were interrogated by mail with a standardised questionnaire. Surgery was considered successful when the patient was able to achieve satisfactory erection resulting in intercourse without employing any other therapy. Improvement was de®ned by the ability to achieve erection with intracavernous injection. Any other cases were considered as failures.
Results
At the time of surgery, mean age was 47.5 AE 11 y (range 20±74). Nine percent of these patients were known to be diabetic, 23% were smokers, 11% had hypertension and 9% had hypercholesterolemia. The impotence was characterised as pure arteriopathy in 39 patients (33.9%), pure veno-cavernous impotence in 23 (20%) and mixed in 53 cases (46.1%). In 91%, the vascular pathology was considered as the main cause of impotence, in 10 patients (9%) another etiology was diagnosed and treated (neuropathy: 4 cases, psychiatric disease: 4 cases, hypogonadism: 2 cases).
Median duration of history of impotence was 3.3 y (range 1±12). With a median postoperative follow-up of 17 months (range 1±120), the surgical treatment was considered successful in 55 patients (47.8%), 17 patients (14.6%) had improved and 43 patients (37.4%) failed to recover any erection or to maintain an initial good result. We were not able to ®nd any factor statistically correlated with the result of the surgery ( Table 2) . We observed an impairment of our initial results with time since the surgical outcome at the ®rst post-operative consultation was considered as good in 80 cases (69.5%) or improved in 14 cases (12.2%).
Interestingly, our results differed according to the etiology of impotence and to the surgical procedure ( Table 3) . Analysis of surgical outcomes by preoperative etiology revealed a signi®cantly better result in patients with pure venogenic impotence compared to patients with pure arteriogenic impotence (P 0.05), the results of patients with mixed impotence being intermediate. Analysis of surgical outcomes by operative procedures showed that in patients with pure arteriogenic impotence, better results were obtained with DDVA compared to the Michal II procedure, although the difference was not statistically signi®cant (P 0.064). However this result was observed with a greater mean follow-up and despite more severe penile arterial disease in the group of patients treated with DDVA. The same results were obtained in patients with mixed arteriogenic and venogenic impotence, the difference between the outcome of DDVA and Michal II procedure was not statistically signi®cant (P 0.12). In each subgroup, we were not able to identify any factor among age, diabetes, hypertension, smoking, dyslipemia, duration of impotence statistically correlated with the prognostic. An evaluation of the etiology of failure was carried out in 19 cases using the same explorations as the initial evaluation of impotence. Occlusion of the graft was observed only in 3 cases. Progression of the arteriopathy was observed in 5 cases, representing 50% of the failures in the treatment of arteriogenic impotence. Progression or apparition of venogenic impotence was found in 7 cases, psychogenic impotence was found in 3 cases.
Overall, 32 postoperative complications were experienced in 30 patients, including parietal hematoma in 9 (7.8%), parietal sepsis in 4 (3.5%), urinary infection in 3 (2.6%) and pulmonary infection in 1 (0.9%), glandular hypervascularisation in 15 patients representing 21% of the DDVA procedure. Glandular hypervascularisation was treated by local care in all cases, plus reduction of thē ow in the graft by a banding procedure around the inferior epigastric artery in 11 cases (73%) with maintenance of a good erectile function in 13 cases (86%) (Figures 6 to 8) . No cases of priapism were observed, no patients complained of penile shortening or numbness.
Discussion
The diagnostic evaluation of impotent men remains controversial although its modalities has dramatically improved during the past decade. The results of microvascular penile revascularisation should be analysed according to the etiology of impotence. 17 For patients with pure arteriogenic impotence, the Michal II procedure seems to be the most physiological solution by creating a bypass of the distal arterial occlusion, providing new arterial blood¯ow into the cavernous bodies that remains under the vasomotor control of the penile vessels. 26 In our study, progression of the arteriopathy was responsible for 50% (5 out of 10) of failure in this group, despite preoperative patent distal dorsal arteries. It should be pointed out that concordant results were published by Hatzichristou 27 who showed the presence of histologic atherosclerosis lesions on the penile dorsal artery in more than 50% of the patients selected for an arterial bypass. The inferior epigastric artery is in our experience never involved in the atherosclerotic process. 40 These facts are in favor of the use of DDVA even in pure arteriogenic impotence. We report a 20% failure rate with DDVA in such a setting, as it has been reported by others. 6,15±16,28 The theoretical advantage of DDVA is the absence of any degenerative atherosclerotic process in the receiving vessel. Arterial bypass should probably be reserved for selective candidates with segmental arterial disease secondary to trauma. 22 Our best success rate was obtained with patients with pure venogenic impotence treated with DDVA. Our results were con®rmed by other authors 2 and DDVA is undoubtedly superior to any procedure of reduction of the cavernosa corpora out¯ow. 29, 30, 34 The pathological conditions responsible for venogenic impotence are unclear but venous leakage seems to be correlated with a loss of compliance of the corpora cavernosa 35 and a de®ciency of muscular relaxation. 36, 37 Surgical correction of venous out¯ow is deceptive because of the anatomic complexity of penile venous network. 29, 32, 33 Appearance of new sites of venous leakage has been demonstrated to occur after penile vein ligation for venogenic impotence. 38 Despite extensive assessment, we could not de®ne any signi®cant relationship between preoperative data and surgical outcome. The importance of the cavernosa muscular pathology, which can be studied by electromyography (SPACE) 39 or by biopsy, 2,40 may constitute a useful complementary test.
Mixed vasculogenic incompetence, associating arteriopathy and veno-cavernous leakage, is a frequent cause of impotence but is rarely speci®cally taken into account. As expected, considering our results with arteriogenic and venogenic impotence, the best success rate was obtained with DDVA while arterial bypass was disappointing. The population in the two subgroups was similar although we did not conduct a prospective study. Cookson 17 con®rmed the insuf®ciency of arterial bypass to treat mixed vasculogenic impotence patients, while other authors reported similar success rates to ours with DDVA. 2, 14, 16 DDVA is the most effective procedure to restore erection, our results have been con®rmed by other studies. 2,6,14±16,18,24,29,42 Nevertheless, the hemodynamic consequences of this operation are still controversial. It is not yet known whether DDVA increases intracavernosal blood¯ow. On early postop angiographic controls, no opaci®cation of the cavernous bodies could be demonstrated in the absence of a venocavernous ®stula 12 and anatomic emissary vein valves have been demonstrated in 36% of patients. 41 On the other hand, these valves may have been rendered incompetent by the arterial pressure gradient 13 and some other authors reported elevation of the cavernosal pressure after DDVA. 2 Since the hemodynamic consequences of DDVA are unclear, nothing is known about its biological consequences. The cavernous oxygen tension or the expression of numerous endothelial mediators may be modi®ed by this procedure and should be studied.
Graft patency and even normal penile hemodynamic conditions can be achieved without restoration of potency 2 and the results of this procedure should be estimated on the patient and partner's satisfaction. Although it is dif®cult to explain how DDVA works, numerous authors were able to reproduce our success rate with this procedure.
Graft occlusion rarely occurs using this procedure (1.5% in our experience) and is not imputable to venous parietal impairment since the arterialised vein does not suffer any histologic modi®cations. 43 The main complication of this procedure is glandular hypervascularisation, whose frequency is evaluated between 5±22%. 14, 44 However, in our experience, this complication can be successfully treated by reduction of the blood¯ow into the graft, without impairment of potency.
Conclusions
Microvascular surgery is successful in selected patients with vasculogenic impotence. Our results are consistent with many other studies with a success rate between 60 and 70%, particularly for patients treated with the DDVA procedure. However, even with our rigorous screening, about a third of our patients remained impotent and we were not able to de®ne any prognostic factor statistically correlated with surgical outcome. Moreover, if DDVA seems to be the most effective procedure, many questions are still unanswered about the way it restores erection. Thus signi®cant progress is still needed in our understanding of erectile physiology, diagnostic capabilities and revascularisation consequences to improve patients selection. Hopefully, a better selection of candidate to penile microvascular revascularization will lead to more restrained indications and hopefully to better long-term success rate.
